Effects of icariin on cGMP-specific PDE5 and cAMP-specific PDE4 activities

Asian Journal of Andrology

Volumn 5, Issue 1, 2003, Pages 15-18

  Xin, Zong Cheng ^a   Kim, E K ^b   Lin, C S ^c   Liu, W J ^a   Tian, L ^a   Yuan, Y M ^a   Fu, J ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

^c NONE

Author keywords

cGMP; Icariin; PDE5; Penile erection

Indexed keywords

CYCLIC AMP; CYCLIC GMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; ICARIIN; PAPAVERINE; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV; SILDENAFIL; TRITIUM;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEVICE; DRUG POTENCY; DRUG SELECTIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME ISOLATION; ISOTOPE LABELING; LIVER; THROMBOCYTE;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; 3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; CYCLIC AMP; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; FLAVONOIDS; HUMANS; MALE; PAPAVERINE; PENILE ERECTION; PHOSPHODIESTERASE INHIBITORS; RATS; TRITIUM;

EID: 0037360716     PISSN: 1008682X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Lue T F. Erectile Dysfunction. N Engl J Med 2000; 342: 1802-13.
2. Burnett AL, Lowenstein CJ, Bredt DS, Chang TSK, Snyder SH. Nitric oxide: a physiologic mediator of penile erection. Science 1992; 257: 401-3.
3. Lin CS, Ho HC, Chen KC, Lin G, Nunes L, Lue TF. Intracavernosal injection of vascular endothelial growth factor induces nitric oxide synthase isoform. BJU Int 2002; 89: 955-60.
4. TF Lue, KL Lee. Pharmacotherapy for erectile dysfunction. Chin Med J (Engl), 2000; 113: 291-8.
5. Choi YD, Xin ZC, Choi HK. Effect of Korean ginseng on the rabbit corpus cavernosal smooth muscle. Int J Impot Res 1998; 10: 37-43.
6. Knispel HH, Goessl C, Beckman R. Nitric oxide mediates relaxation in rabbit and human corpus cavernosum smooth muscle. Urol Res 1992; 20: 253-7.
7. Buvat J, Lemaire A, Herbaut-Buvat M. Intracavernosal pharmacotherapy: comparison of moxisylyte and prostaglandin E1. J Impt Res 1996; 8: 41-6.
8. Goldstein I, Payton T, Padma-Nathan H. Therapeutic roles of intracavernosal papaverine. Cardiovasc Intervent Radiol 1988; 11: 237-9.
9. Otani T. Intracavernous injection test by prostaglandin E1. Nippon Rinsho 2002; 60 (Suppl 6): 173-7.
10. Pietta PG, Mauri PL, Manera E, Ceva PL, Rava A. An approved HPLC determination of flavonoids in medical plant extracts. Chromatographia 1989; 27: 509-12.
11. Liang HR, Vuorela P, Vuorela H, Hiltinen R. Isolation and immunomodulatory effect of flavonol glycosides from epimedium hunense. Plants Med 1997; 63: 316-9.
12. Du Q, Xia M, Ito Y. Purification of icariin from the extract of Epimedium segittatum using high-speed counter-current chromatography. J Chromatogr A 2002; 962: 239-41.
13. Linuma M, tanaka T, Sakakibara N, Mizuno M, Matsuda H, Shiomoto H, et al. Phagocytic activity of leaves of epimedium species on mouse reticuloendothelial system. Yakugaku Zasshi 1990; 110: 179-85.
14. Lee MK, Choi YJ, Sung SH, Shin DI, Kim JW, Kim YC. Antihepatotoxic activity of icariin, a major constituent of epimedium koreanum. Planta Med 1995; 61: 523-6.
15. He W, Sun H, Yang B, Zhang D, Kabelitz D. Immunoregulatory effects of the herba epimediia glycoside icariin. Arzneimittelforschung 1995; 45: 910-3.
16. Zhao Y, Cui Z, Zhang L. Effects of icariin on the differentiation of HL-60 cells. Zhonghua Zhong Liu Za Zhi. 1997; 19: 53-5.
17. Niu R. Action of the drug herba epimedii on testosterone of the mouse plasma and its accessory sexual organ before and after processing. Chung Kuo Chung Chao Yao Tsa Chih 1989; 14: 530-2.
18. Zheng J, Luo Y, Meng X, Sun Y, Zhang Y, Dong X, et al. Effects of Sichuan herba epimedii on the concentration of plasma middle molecular substances and sulfhydryl group of "Yang-deficiency" model animal. Chung Kuo Chung Yao Tsa Chih 1995; 20: 238-9.
19. Xin ZC. Kim EK, Tian ZJ, Lin GT, Guo YL. Icariin on relaxation of corpus cavernosm smooth muscle. Chin Sci Bulle 2001; 46: 485-9.
20. Qiao L, Xin ZC, Fu J, Liu WJ, Lin GT, Chen S. Expression of Phosphodiesterase 5 in clitoris cavernosum and effect of Icariin on cGMP levels in vitro. Chin J Urol 2002; 23: 670-2.
21. Fu J, Qiao L, Jin TY, Lin GT, Wang YY, Xin ZC. Effects of Icariin on cGMP synthesis in corpus cavernosm of rabbits. Chinese Phamarcological Bulletin 2002; 18: 430-2.
22. Boolell M, Allen MJ, Ballard SA, Gepi-Attes S, Muirhead GJ, Naylor AM, et al. Sildenafil:a orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996; 8: 47-52.
23. Francis SH, Turko IV, Corbin JD. Cyclic nucleotide phosphodiesterases: relating structure and function. Prog Nucleic Acid Res Mol Biol 2001; 65: 1-52.
24. Soderling SH, Beavo JA. Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions. Curr Opin Cell Biol 2000; 12: 174-9.
25. Loughney K and Ferguson K. Identification and quantification of PDE isozymes and subtypes by molecular biological methods. In: Schudt C, Dent G, Rabe KF, editors. Phosphodiesterase inhibitors. San Diego: Academic Press; 1996. 99: 1-19.
26. Lin CS, Chow S, Lau A, Tu R, Lue. Human PDE5A gene encodes three PDE5 isoforms from two alternate phosphodiesterases: functional implications of multiple isoforms. Phyiol Rev 1995; 75: 725-8.